HCAT analyst estimates

Health Catalyst (HCAT) analyst ratings, the average price target and its range, and every firm's latest call.

HCAT analyst ratings and price targets

DateFirmCallTarget
Aug 20, 2026Canaccord GenuityCanaccord downgrades Health Catalyst to Hold on transformation risk$1.80
Jul 21, 2026Canaccord GenuityHealth Catalyst price target raised to $3 from $2 at Canaccord$3.00
Jun 26, 2026Wells FargoHealth Catalyst price target raised to $1.75 from $1 at Wells Fargo$1.75
May 12, 2026StephensHealth Catalyst price target lowered to $1.75 from $2 at Stephens$1.75
Mar 13, 2026Canaccord GenuityHealth Catalyst Inc. (HCAT) PT Lowered to $2 at Canaccord$2.00
Mar 13, 2026Raymond JamesHealth Catalyst Inc. (HCAT) PT Lowered to $3 at Cantor Fitzgerald; No Turnaround Yet$3.00
Oct 8, 2025KeyBancHealth Catalyst price target lowered to $4 from $5 at KeyBanc$4.00
Oct 8, 2025Evercore ISIHealth Catalyst price target lowered to $3 from $4 at Evercore ISI$3.00
Aug 29, 2025Summit Redstone PartnersHealth Catalyst price target lowered to $5 from $9 at Canaccord$5.00
Aug 29, 2025Canaccord GenuityHealth Catalyst price target lowered to $5 from $9 at Canaccord$5.00
Apr 16, 2025KeyBancHealth Catalyst price target lowered to $5 from $7 at KeyBanc$5.00
Mar 6, 2025StephensHealth Catalyst price target lowered to $5 from $7 at Stephens$5.00
Jan 14, 2025RBC CapitalHealth Catalyst price target lowered to $7 from $9 at RBC Capital$7.00
Sep 3, 2024Canaccord GenuityCanaccord Genuity Reiterates Buy Rating on Health Catalyst Inc. (HCAT)$11.00
Aug 26, 2024Piper SandlerHealth Catalyst Inc. (HCAT) PT Lowered to $11 at Piper Sandler$11.00